Increased activity of procoagulant factors in patients with small cell lung cancer.
Small cell lung cancer (SCLC) patients have augmented risk of developing venous thromboembolism, but the mechanisms triggering this burden on the coagulation system remain to be understood. Recently, cell-derived microparticles carrying procoagulant phospholipids (PPL) and tissue factor (TF) in thei...
Guardado en:
Autores principales: | Shona Pedersen, Anne Flou Kristensen, Ursula Falkmer, Gunna Christiansen, Søren Risom Kristensen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e5944bdfb83b4c8b9bb3e2e9e0d318e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Shotgun-based proteomics of extracellular vesicles in Alzheimer’s disease reveals biomarkers involved in immunological and coagulation pathways
por: Jonas Ellegaard Nielsen, et al.
Publicado: (2021) -
Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors
por: Daniël Verhoef, et al.
Publicado: (2017) -
Golden berry 4β-hydroxywithanolide E prevents tumor necrosis factor α-induced procoagulant activity with enhanced cytotoxicity against human lung cancer cells
por: Kan-Yen Hsieh, et al.
Publicado: (2021) -
Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes
por: Zhang C, et al.
Publicado: (2020) -
Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity
por: Hernández MR, et al.
Publicado: (2012)